
Eli Lilly (LLY): Growth Power Meets Rich Valuation
Eli Lilly delivered 48% Q2 revenue growth and raised full-year guidance, but the stock already prices in a lot of that momentum. Hold reflects strong execution, a deep pipeline, and a premium valuation that limits upside.










